AGING POPULATION
COSTS AND SPENDING
FOR-PROFIT
MORE NOT ALWAYS BETTER
HEALTH MORE THAN HEALTHCARE
PATIENT PAYS
SUSTAINABILITY
WAITING FOR CARE
  • Home
  • About
    • Experts
  • Contact
  • Backgrounders
  • Commentaries
    • English
    • French
  • Our Videos
    • Our Videos
    • Featured Videos
  • Resources

Evidence Network
rsz_morgan_2012
Skip to content
  • Home
  • About
    • Experts
  • Contact
  • Backgrounders
  • Commentaries
    • English
    • French
  • Our Videos
    • Our Videos
    • Featured Videos
  • Resources
     
Share
Print Friendly and PDF

Steve Morgan

Steve Morgan, PhD
University of British Columbia
Access to, Financing of Prescription Drugs

Dr. Steve Morgan is Associate Professor at the University of British Columbia and Associate Director of the Centre for Health Services and Policy Research. An expert in pharmaceutical policy, Dr. Morgan combines quantitative health services research with comparative policy analysis to help identify policies that achieve balance between three sometimes-competing goals: providing equitable access to necessary care, managing health expenditures, and promoting valued innovation.

Dr. Morgan earned degrees in economics from the University of Western Ontario, Queen’s University, and the University of British Columbia; and received postdoctoral training at McMaster University. He is a recipient of career awards from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research, an alumnus of Harkness Fellowships in Health Care Policy, and a former Labelle Lecturer in Health Services Research.

Twitter: @SteveUBC

Download a new hi-res photo of Steve Morgan

Commentaries by Dr. Steve Morgan:

Moving to income-based drug coverage is the wrong prescription
Our pharmacare system in Canada is designed to fail — and it’s costing us billions
How universal pharmacare might just save our health care system
Time to repair the drug patent process in Canada
Why, in a sea of pin, are so many cancer patients in the red? // Pourquoi, dans une mer de rose, tant de patientes atteintes de cancer se retrouvent-elles dans le rouge?
Time to fight for pharmacare //  Le temps est venu de se battre pour l’assurance médicaments

Comments are closed.


We have experts who are ready and able to answer questions and connect you with the evidence on issues in Canadian health policy.


We are here to help you quickly make sense of complex health policy issues. We can help you understand what evidence is out there and how to put new evidence into context.

Review the evidence, browse how these topics have been discussed in the news or go directly to our list of health policy experts.



Keep up to date with newly-released press releases and be the first to hear about our updates and new topics.

Webinar by Dr. John Lister: What we’ve learned working with journalists across Europe on health reporting (podcast link to follow shortly)
Backgrounder: The price of prescription drugs in Canada

Prepared by the Science Media Centre of Canada with resources from Evidencenetwork.ca

Invest in home care

Windsor Star



AGING POPULATION
COSTS AND SPENDING
MORE NOT ALWAYS BETTER
HEALTH MORE THAN HEALTHCARE
FOR-PROFIT
PATIENT PAYS
SUSTAINABILITY
WAITING FOR CARE


Evidence Network
Proudly powered by WordPress.

  • PRIVACY STATEMENT
  • TERMS OF USE
  • CONFLICT OF INTEREST POLICY
  • CONTACT
Site development provided in part by:
     Copyright EvidenceNetwork.ca